EUVIMEDEUVIMED entdecken
Crossref

Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics

Mirabella Zhao iD, Lene Buhl Riis iD, Bobby Lo, Mohamed Attauabi, Pernille Dige Ovesen, Mads Damsgaard Wewer, Lone Larsen iD, Anders Dige, Christian Lodberg Hvas, Anja Poulsen iD, Dagmar Christiansen, Zainab Gassem Nagras und 5 weitere

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izae287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Mirabella Zhao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Gastro Unit - Medical Section, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colectomy, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Takeda Pharma A/S.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biological treatment failure is common in patients with ulcerative colitis (UC), but the predictive value of baseline histological activity is unknown.

Aims

We aimed to investigate the associations between baseline histological activity and outcomes after biological treatment in patients with UC.

Methods

Adult biological-naïve patients with UC (n = 150) were followed prospectively during biological treatment. Histological activity was assessed using the Nancy Index and Geboes score. Endoscopic activity was assessed using the Mayo Endoscopic Subscore (MES). Associations with outcomes were assessed in multivariable models. Associations between histological, endoscopic, and biochemical activity were assessed using Spearman’s correlation.

Results

In biological-treated patients with UC, severe histological activity at baseline was independently associated with colectomy risk during the induction period (Nancy 2 vs 4: odds ratio [OR] 0.18, 95% CI 0.01-0.61, P = 0.024; Nancy 3 vs 4: OR 0.12, 95% CI 0.02-0.63, P = .019; Geboes 3 vs 5: OR 0.06, 95% CI 0.00-0.57, P = .033; Geboes 4 vs 5: OR 0.13, 95% CI 0.01-0.69, P = 0.032) and total follow-up (Nancy 2 vs 4: HR 0.23, 95% CI 0.06-0.98, P = 0.046; Nancy 3 vs 4: HR 0.13, 95% CI 0.04-0.47, P = 0.002; Geboes 4 vs 5: HR 0.28, 95% CI 0.08-0.93, P = 0.038). Meanwhile, baseline MES was not independently associated with colectomy risk. Histological activity was correlated with MES and the levels of C-reactive protein, hemoglobin, and albumin, but not calprotectin.

Conclusions

Severe histological activity at baseline as characterized by a higher Nancy Index or Geboes score independently predicted colectomy risk in biological-treated UC patients, whereas MES did not. Thus, histological assessment should be encouraged before initiating biological treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeColectomyBiological ProductsHumansFemaleMaleAdultMiddle AgedProspective StudiesSeverity of Illness IndexFollow-Up StudiesColonoscopyPrognosisRisk FactorsC-Reactive Protein

Stichwörter der Autor:innen

biological treatmenthistopathologysurgery riskulcerative colitis

Substanzen

Biological ProductsC-Reactive Protein

Autor:innen und Institutionen

  • Gastro Unit - Medical Section, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
  • Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
  • Department of Pathology, Herlev Hospital-University of Copenhagen, Herlev, Denmark.
  • Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark.
  • Department of Gastroenterology and Hepatology, Herlev Hospital-University of Copenhagen, Herlev, Denmark.
  • Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.

ORCID-Profile: Mirabella Zhao, Lene Buhl Riis, Lone Larsen, Anja Poulsen, Jakob Seidelin, Johan Burisch

Förderung

  • Takeda Pharma A/S

Zitieren

APA

Zhao, M., Riis, L. B., Lo, B., Attauabi, M., Ovesen, P. D., Wewer, M. D., Larsen, L., Dige, A., Hvas, C. L., Poulsen, A., Christiansen, D., Nagras, Z. G., Dahlin, P., Petersen, A. M., Bendtsen, F., Seidelin, J., & Burisch, J. (2025). Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae287

Vancouver

Zhao M, Riis LB, Lo B, Attauabi M, Ovesen PD, Wewer MD, et al. Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae287

BibTeX
@article{Zhao2025,
  author = {Zhao, Mirabella and Riis, Lene Buhl and Lo, Bobby and Attauabi, Mohamed and Ovesen, Pernille Dige and Wewer, Mads Damsgaard and Larsen, Lone and Dige, Anders and Hvas, Christian Lodberg and Poulsen, Anja and Christiansen, Dagmar and Nagras, Zainab Gassem and Dahlin, Pernille and Petersen, Andreas Munk and Bendtsen, Flemming and Seidelin, Jakob and Burisch, Johan},
  title = {Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izae287}
}
Kostenlos starten →